Music Activity, Data and Artificial Intelligence = Window to Cognitive Health.
Music, notably piano playing, involves multiple sensory processing, comprehension, quasi-simultaneous decision making and action execution. Simply put, it is one of the best ways to evaluate brain functions and to train minds.
Our Products:
1) Ipsilon Cognitive Test
Web-based computerized cognitive assessment aid. Expected launch in 2Q 2020 in EU as medical device certification class 1 device (software as medical device).
Usability study with Parkinson's disease patients has been successfully completed with Asociacion Parkinson Madrid in June, 2019.
Non-stigmatizing, game-like and fun, easy to implement as routine brain assessment.
Suitable for pre-clinical and early dementia, often caused by chronic illnesses.
Operable by non-specialist, as a bridging tool between home care and hospital appointments.
Features:
What it does: evaluate executive function, inhibition control, attention, memory function by quantifying learning to assess brain functionalities.
What inputs/ outputs it assesses: comprehension (visuo-spatial/motor encoding) and time-stamped finger responses.
What advantage?: eliminates language biases. Elicit multi-sensory responses, monitoring capability of many brain regions and functionalities.
What value proposition?: compatible to research-grade cognitive batteries, can be combined with EEG and eye tracking. Can be used as dementia prevention tool.
Product availability: as an web-based app (software as service) for tablets, by subscription.
Intended customers: healthcare providers.
Specific feature: collected data forwarded to primary care physicians; Rhythmic stimulation for patients with movement disorder.
2) Dementia Risk Assessment
Ipsilon's artificial neural network tool to analyze the collected data and detect mild cognitive impairment (MCI) and early dementia among risk groups.
Features:
What it does: detect cognitive abnormalities associated with MCI and early dementia, calculates likelihood of developing dementia.
What data does it use?: Ipsilon Test collects user response data and our algorithm analyzes the data and determine likelihood of developing dementia.
What advantage?: MCI and early dementia are hard to detect. Music playing reveals slightest cognitive abnormalities.
What purpose?: To create personal baseline, enable early detection, providing access to early intervention to delay onset and/or preserve cognitive functionalities.
Side effects?: No. Non-invasive.
Targeted conditions:
Mild Cognitive Impairment (MCI) and vascular dementia; Alzheimer's Disease; Alzheimer's Disease Related Dementia
Targeted customers:
Healthcare providers
Assisted living facilities
Insurance (elderly cognitive fitness for driving; quantitative dementia threshold for insurance-related products)
4) Consultancy over implementing know-how of music to optimize performances available (with CEO, Yayoi Sakaki).
-please inquire us through Contact Us.
-example of applicable domains: ADHD attention remedy, athletic training, public speaking, simulated performance training for corporate groups
Our One Pager and Investor Deck are available upon request.
One-pager can be seen at Slideshare of Yayoi Sakaki, Founder and inventor.
Patend pending with our methodologies.
We are/ have been mentored through incubators/accelerator at:
InnoLabs 2nd Open Call Accelerator through delivering partner, Norway Health Tech, November, 2018 to August, 2019)
HighTechXL accelerator, Eindhoven, The Netherlands (http://www.hightechxl.com/), September 4 to December 6, 2017
ENDuRE Project (University of Pisa, www.endureproject.eu/), May 30, 2016 to June 11, 2016
Erasmus Center for Entrepreneurship (http://ece.nl/), May 6, 2016 to July 1, 2016
key words: aging, Alzheimer's, dementia, MCI, executive function, mental performance, brainwaves, music, piano, digital therapy, sensory stimulation, cognition, cognitive wellness, mindfulness.